Related Experiment Video
Updated: Nov 25, 2025
08:02
In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
Published on: September 23, 2021
2.8K
Extracellular Vesicles Orchestrate Immune and Tumor Interaction Networks
Kevin Ho Wai Yim1, Ala'a Al Hrout1, Simone Borgoni1
1Institute of Experimental Immunology, University of Zurich, 8057 Zurich, Switzerland.
Cancers
|December 15, 2020
Summary
Extracellular vesicles (EVs) mediate communication between immune and tumor cells. This review explores their role in immunity, infections, and cancer, highlighting diagnostic and therapeutic potential.
Area of Science:
- Immunology
- Cell Biology
- Cancer Research
Background:
- Extracellular vesicles (EVs) are key mediators of intercellular communication.
- EV subpopulations vary in size, surface markers, cargo, and biological functions.
- EVs play critical roles in immune and tumor interactions.
Purpose of the Study:
- To synthesize recent findings on immune-tumor EV-based communication.
- To discuss the role of EVs in physiological, viral, and tumorigenic conditions.
- To explore future prospects for immune-tumor EVs in diagnostics and therapeutics.
Main Methods:
- Literature review and synthesis of current research on EVs.
- Analysis of proteomic and epigenomic mechanisms of EV signaling.
- Discussion of potential diagnostic and therapeutic applications.
Main Results:
- EVs mediate complex intercellular communication networks.
- EVs are involved in immune responses, viral infections, and cancer progression.
- EV surface markers and nucleic acid cargo are crucial for signaling.
Conclusions:
- Immune-tumor EVs represent a significant area of research.
- EVs hold promise for novel diagnostic and therapeutic strategies in oncology and immunology.
- Further research is needed to fully elucidate EV functions and applications.
More Related Videos
Related Concept Videos
02:17The Tumor Microenvironment
7.3K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.3K
01:36Overview of Exosomes
3.2K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.2K
01:45Vesicular Tubular Clusters
2.8K
After budding out from the ER membrane, some COPII vesicles lose their coat and fuse with one another to form larger vesicles and interconnected tubules called vesicular tubular clusters or VTCs. These clusters constitute a compartment at the ER-Golgi interface known as ERGIC (Endoplasmic Reticulum Golgi Intermediate Compartment). The ERGIC is a mobile membrane-bound cargo transport system that sorts proteins secreted from ER and delivers them to the Golgi.
With the help of motor proteins such...
With the help of motor proteins such...
2.8K
01:27Tumor Immunotherapy
884
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
884
01:38Intralumenal Vesicles and Multivesicular Bodies
4.4K
Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...
4.4K
02:53Adaptive Mechanisms in Cancer Cells
6.3K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.3K